Injectable Nanoengineered Adhesive Hydrogel for Treating Enterocutaneous Fistulas.
Enterocutaneous Fistula
adhesive
dopamine
gelatin
hydrogel
nanosilicate
Journal
Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
pmc-release:
01
01
2025
medline:
11
3
2024
pubmed:
11
3
2024
entrez:
11
3
2024
Statut:
ppublish
Résumé
Enterocutaneous fistula (ECF) is a severe medical condition where an abnormal connection forms between the gastrointestinal tract and skin. ECFs are, in most cases, a result of surgical complications such as missed enterotomies or anastomotic leaks. The constant leakage of enteric and fecal contents from the fistula site leads to skin breakdown and increases the risk of infection. Despite advances in surgical techniques and postoperative management, ECF accounts for significant mortality rates, estimated between 15-20%, and causes debilitating morbidity. Therefore, there is a critical need for a simple and effective method to seal and heal ECF. Injectable hydrogels with combined properties of robust mechanical properties and cell infiltration/proliferation have the potential to block and heal ECF. Herein, we report the development of an injectable nanoengineered adhesive hydrogel (INAH) composed of a synthetic nanosilicate (Laponite
Identifiants
pubmed: 38465268
doi: 10.1016/j.actbio.2023.10.026
pmc: PMC10919932
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
231-246Déclaration de conflit d'intérêts
Conflict of Interest The authors declare no conflict of interest. Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.